Table 3.
Multivariable model of mortality
| In-hospital mortality (N = 514) |
||
|---|---|---|
| Characteristic | Adjusted Odds ratio (95% CI) |
P-value |
| Average daily RBC transfusion volume (10 mL/kg) | 1.09 (1.02, 1.16) | 0.009 |
| Bleeding requiring a transfusion on any study day | 1.23 (0.79, 1.92) | 0.366 |
| Primary ECMO indication | 0.042 | |
| Respiratory | Reference | |
| Cardiac | 1.48 (0.87, 2.49) | |
| ECPR | 2.40 (1.21, 4.76) | |
| Mean daily partial pressure of oxygen in arterial blood (10 mmHg) | 1.04 (1.02, 1.07) | 0.002 |
| Hepatic organ failure on at least one study day | 2.46 (1.60, 3.78) | <.001 |
| Renal organ failure on at least one study day | 2.49 (1.61, 3.85) | <.001 |
| Immunocompromised | 2.83 (1.29, 6.20) | 0.010 |
| Chronic neurologic condition | 0.20 (0.04, 0.97) | 0.046 |
| Meconium aspiration syndrome | 0.15 (0.04, 0.55) | 0.004 |
| Congenital diaphragmatic hernia | 2.82 (1.42, 5.60) | 0.003 |
RBC = red blood cell. ECMO = extracorporeal membrane oxygenation. ECPR = extracorporeal cardiopulmonary resuscitation. Additional variables which were considered for inclusion in the multivariable model include: weight, pre-ECMO PRISM III score, baseline immunocompromised state, ICU location of ECMO care, mode of ECMO, hospital LOS prior to ECMO, ICU LOS prior to ECMO, massive transfusion on any study day, mean daily central venous oxygen saturation (SvO2), mean daily partial pressure of oxygen in arterial blood, duration of ECMO, mean daily ECMO flow rate, hepatic organ failure on at least one study day, renal organ failure on at least one study day, thrombotic event, and diagnoses of: cardiac arrest, acquired cardiovascular disease, congenital cardiovascular disease, pertussis or sepsis, neurologic condition, meconium aspiration syndrome, congenital diaphragmatic hernia, persistent pulmonary hypertension of the newborn, and congenital anomaly or chromosomal defect.